Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Abid Oueslati

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Neurosciences
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
T-2-50
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 49119 / +1 418-525-4444, poste 42296
Télécopieur(s)
Courriel(s)
Abid.Oueslati@crchudequebec.ulaval.ca

 https://www.oueslati-lab.com

Projet(s) de recherche actif(s)

Publications récentes (voir toutes les publications de ce chercheur)

Dahmene M, Oueslati A, Berard M. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated alpha-Synuclein-selective Autophagic Degradation. The Journal of biological chemistry,  2017. 292: 3919-3928
Jeon I, Cicchetti F, Cisbani G, Lee S, Li E, Bae J, Lee N, Li L, Im W, Kim M, Kim HS, Oh SH, Kim TA, Ko JJ, Aube B, Oueslati A, Kim YJ, Song J. Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta neuropathologica,  2016. Epub
Oueslati A. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? Journal of Parkinson's disease,  2016. 6: 39-51
Fares MB, Maco B, Oueslati A, Rockenstein E, Ninkina N, Buchman VL, Masliah E, Lashuel HA. Induction of de novo alpha-synuclein fibrillization in a neuronal model for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America,  2016. 113: E912-21
Oueslati A, Lovisa B, Perrin J, Wagnieres G, van den Bergh H, Tardy Y, Lashuel HA. Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease. PLoS ONE,  2015. 10: e0140880
Mbefo M, Fares MB, Paleologou K, Oueslati A, Yin G, Tenreiro S, Pinto M, Outeiro T, Zweckstetter M, Masliah E, Lashuel HA. Parkinson disease mutant E46K enhances alpha-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo. The Journal of biological chemistry,  2015. 290: 9412-27
Mahul-Mellier AL, Fauvet B, Gysbers A, Dikiy I, Oueslati A, Georgeon S, Lamontanara AJ, Bisquertt A, Eliezer D, Masliah E, Halliday G, Hantschel O, Lashuel HA. c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. Human molecular genetics,  2014. 23: 2858-79
Khalaf O, Fauvet B, Oueslati A, Dikiy I, Mahul-Mellier AL, Ruggeri FS, Mbefo MK, Vercruysse F, Dietler G, Lee SJ, Eliezer D, Lashuel HA. The H50Q mutation enhances alpha-synuclein aggregation, secretion, and toxicity. The Journal of biological chemistry,  2014. 289: 21856-76
Oueslati A, Ximerakis M, Vekrellis K. Protein Transmission, Seeding and Degradation: Key Steps for alpha-Synuclein Prion-Like Propagation. Experimental neurobiology,  2014. 23: 324-36
Oueslati A, Schneider BL, Aebischer P, Lashuel HA. Polo-like kinase 2 regulates selective autophagic alpha-synuclein clearance and suppresses its toxicity in vivo. Proceedings of the National Academy of Sciences of the United States of America,  2013. 110: E3945-54
© 2017 Tous droits réservés Centre de recherche du CHU de Québec